P253 ARV-471, a PROTACĀ® estrogen receptor (ER) degrader in advanced ER+/human epidermal growth factor receptor 2 (HER2)- breast cancer: phase 2 expansion (VERITAC) of a phase 1/2 study
Titel:
P253 ARV-471, a PROTACĀ® estrogen receptor (ER) degrader in advanced ER+/human epidermal growth factor receptor 2 (HER2)- breast cancer: phase 2 expansion (VERITAC) of a phase 1/2 study
Auteur:
Hurvitz, S.A Schott, A.F Ma, C. Hamilton, E.P Nanda, R. Zahrah, G. Hunter, N. Tan, A.R Telli, M.L Mesias, J.A. Jeselsohn, R. Munster, P. Lu, H. Gedrich, R. Mather, C. Parameswaran, J. Han, H.S Wirth, S.